Baxter-Lowe L, Wang T, Kuxhausen M, Spellman S, Maiers M, Lee S
Clin Transplant. 2024; 38(11):e15478.
PMID: 39512128
PMC: 11840805.
DOI: 10.1111/ctr.15478.
Bang S, Shim S
J Rheum Dis. 2024; 31(4):200-211.
PMID: 39355544
PMC: 11439634.
DOI: 10.4078/jrd.2024.0051.
Dashti M, Malik M, Nizam R, Jacob S, Al-Mulla F, Thanaraj T
Front Genet. 2024; 15:1407285.
PMID: 38859936
PMC: 11163123.
DOI: 10.3389/fgene.2024.1407285.
Madbouly A, Bolon Y
Front Genet. 2024; 15():1375352.
PMID: 38560292
PMC: 10978785.
DOI: 10.3389/fgene.2024.1375352.
Yogeshwar S, Muniz-Castrillo S, Sabater L, Peris-Sempere V, Mallajosyula V, Luo G
Brain. 2024; 147(7):2579-2592.
PMID: 38425314
PMC: 11224611.
DOI: 10.1093/brain/awae048.
Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning.
Nilsson J, Kaabinejadian S, Yari H, Kester M, van Balen P, Hildebrand W
Sci Adv. 2023; 9(47):eadj6367.
PMID: 38000035
PMC: 10672173.
DOI: 10.1126/sciadv.adj6367.
Existence of HLA-Mismatched Unrelated Donors Closes the Gap in Donor Availability Regardless of Recipient Ancestry.
Chowdhury A, Maiers M, Spellman S, Deshpande T, Bolon Y, Devine S
Transplant Cell Ther. 2023; 29(11):686.e1-686.e8.
PMID: 37586457
PMC: 10840626.
DOI: 10.1016/j.jtct.2023.08.014.
Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party....
Kharfan-Dabaja M, Labopin M, Ayala E, Bazarbachi A, Blaise D, Vydra J
Hemasphere. 2023; 7(7):e920.
PMID: 37388926
PMC: 10306430.
DOI: 10.1097/HS9.0000000000000920.
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia.
Narayan R, Niroula A, Wang T, Kuxhausen M, He M, Meyer E
Transplant Cell Ther. 2023; 29(7):452.e1-452.e11.
PMID: 36997024
PMC: 10330307.
DOI: 10.1016/j.jtct.2023.03.027.
Human Leucocyte Antigen System and Selection of Unrelated Hematopoietic Stem Cell Donors: Impact of Patient-Donor (Mis)matching and New Challenges with the Current Technologies.
Crocchiolo R, Rombola G
J Clin Med. 2023; 12(2).
PMID: 36675576
PMC: 9862309.
DOI: 10.3390/jcm12020646.
Unrelated Stem Cell Donor HLA Match Likelihood in the US Registry Incorporating HLA-DPB1 Permissive Mismatching.
Gragert L, Spellman S, Shaw B, Maiers M
Transplant Cell Ther. 2023; 29(4):244-252.
PMID: 36623771
PMC: 10040431.
DOI: 10.1016/j.jtct.2022.12.027.
Hematology 2022-what is complete HLA match in 2022?.
Spellman S
Hematology Am Soc Hematol Educ Program. 2022; 2022(1):83-89.
PMID: 36485162
PMC: 9821192.
DOI: 10.1182/hematology.2022000326.
Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection.
Krummey S, Gareau A
Front Immunol. 2022; 13:916200.
PMID: 35990679
PMC: 9390945.
DOI: 10.3389/fimmu.2022.916200.
The Accuracy of Sequence-Specific Oligonucleotide and Real-Time Polymerase Chain Reaction HLA Typing in Determining the Presence of Pre-Transplant Donor-Specific Anti-HLA Antibodies and Total Eplet Mismatches for Deceased Donor Kidney Transplantation.
Larkins N, DOrsogna L, Taverniti A, Sharma A, Chakera A, Chan D
Front Immunol. 2022; 13:844438.
PMID: 35799779
PMC: 9253866.
DOI: 10.3389/fimmu.2022.844438.
Racial disparities in access to alternative donor allografts persist in the era of "donors for all".
Fingrut W, Gyurkocza B, Davis E, Flynn J, Chinapen S, Naputo K
Blood Adv. 2022; 6(20):5625-5629.
PMID: 35675518
PMC: 9642869.
DOI: 10.1182/bloodadvances.2022007814.
HLA-DQ heterodimers in hematopoietic cell transplantation.
Petersdorf E, Bengtsson M, Horowitz M, McKallor C, Spellman S, Spierings E
Blood. 2022; 139(20):3009-3017.
PMID: 35271697
PMC: 9121842.
DOI: 10.1182/blood.2022015860.
Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity.
Laghmouchi A, Kester M, Hoogstraten C, Hageman L, de Klerk W, Huisman W
Front Immunol. 2022; 13:831822.
PMID: 35251023
PMC: 8888658.
DOI: 10.3389/fimmu.2022.831822.
Matching Improves Outcome of Unrelated Hematopoietic Stem Cell Transplantation.
Tsamadou C, Engelhardt D, Platzbecker U, Sala E, Valerius T, Wagner-Drouet E
Front Immunol. 2021; 12:771449.
PMID: 34970261
PMC: 8712639.
DOI: 10.3389/fimmu.2021.771449.
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation.
Buhler S, Baldomero H, Ferrari-Lacraz S, Mamez A, Masouridi-Levrat S, Heim D
Blood Adv. 2021; 5(17):3377-3386.
PMID: 34448833
PMC: 8525224.
DOI: 10.1182/bloodadvances.2020003998.
Influence of HLA-DPB1 mismatches on outcome after allogeneic hematopoietic stem cell transplantation.
Hunziker M, Passweg J, Medinger M
Leuk Res Rep. 2021; 16:100259.
PMID: 34345585
PMC: 8319557.
DOI: 10.1016/j.lrr.2021.100259.